Susan Hasty, Publisher
Table of Contents . . . October 21st, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Gene Therapy - Adenovirus vectors can block viral replication in alveolar macrophages
HIV/AIDS Therapy - Drug-resistant virus increasingly common in newly infected patients
AIDS Therapy - New protease inhibitor held HIV at undetectable levels for 4 years
Assisted Reproduction - HIV infection and/or treatment may affect semen quality
HIV/AIDS Therapy - Milk peptides may yield novel therapies
Women's Health - Cesarean section under spinal anesthesia OK during antiretroviral therapy
AIDS Epidemic - Pan American conference opens with summons to strengthen struggle against AIDS
AIDS Therapy - Phase III, 24-week results for the NEAT trial comparing GW433908 to nelfinavir
Appointments - Vaccine developer expands management team
Blood Safety - TIGRIS instrument system to be used for clinical diagnostic testing
Drug Development - AIDS researchers split GSK award
Epidemiology - HIV rate and risky behavior decline among injection drug users in Baltimore
Epidemiology - Report finds HIV up in Russia, China
HIV Prevention - U.N. development agency starts new push to counter HIV/AIDS in Arab region
HIV Screening - HIV expert encourages Chinese health authorities to use HIV-1 urine test
HIV Transmission - Scientists and health groups call for removal of N-9 from condoms, lubricants
HIV Treatment - Phase III study of Viread shows favorable lipid, mitochondrial DNA profile
HIV/AIDS Therapy - Innovative Australian HIV drug gets green light for further testing
Hepatitis Immunization - Rates remain less than half for gay and bisexual men
Infectious Disease - Prices lowered for HIV/AIDS, antimalarial medicines
Kaposi Sarcoma-associated Herpesvirus - Impact of v-GPCR signaling on host cell biology studied
Restructuring - Company to focus exclusively on Remune
Smallpox - Research finds certain groups at risk for severe reactions from smallpox vaccine
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.